A Comparative Study of PD-L1 Protein Expression Using the Ventana SP263 Diagnostic Assay and PD-L1 mRNA Expression Using RNAscope in Formalin Fixed Paraffin Embedded Samples of Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Urothelial Carcinoma (UC)

被引：0
|
作者：
Duncan, D. [1 ]
Scott, M. [1 ]
Scorer, P. [1 ]
Walker, J. [2 ]
Barker, C. [1 ]
机构：
[1] Precis Med & Genom, Precis Med Labs, Cambridge, England
[2] Precis Med & Genom, Oncol Compan Diagnost Unit, Cambridge, England
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2018年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
P35
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Assessment of heterogeneity of PD-L1 expression in NSCLC, HNSCC, and UC with Ventana SP263 assay.
    Scott, Marietta L.
    Scorer, Paul
    Lawson, Nicola
    Ratcliffe, Marianne J.
    Barker, Craig
    Rebelatto, Marlon
    Walker, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Assessment of PD-L1 mRNA and protein expression in non-small cell lung cancer, head and neck squamous cell carcinoma and urothelial carcinoma tissue specimens using RNAScope and immunohistochemistry
    Duncan, David Jonathan
    Scott, Marietta
    Scorer, Paul
    Barker, Craig
    PLOS ONE, 2019, 14 (04):
  • [3] Inter-rater reliability of programmed death ligand 1 ( PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)
    Williams, G. H.
    Nicholson, A. G.
    Snead, D. R. J.
    Thunnissen, E.
    Lantuejoul, S.
    Cane, P.
    Kerr, K. M.
    Loddo, M.
    Scott, M.
    Scorer, P. W.
    Barker, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Validation of VENTANA (SP263) PD-L1 immunohistochemistry (IHC) assay in formalin-fixed, paraffin embedded (FFPE) cytology samples
    Barker, C.
    Horne, H.
    Scorer, P.
    Roland, B.
    Hayden, D.
    Schnittker, K.
    VIRCHOWS ARCHIV, 2021, 479 : S158 - S159
  • [5] Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay
    Chauhan, Aastha
    Racila, Emilian
    Stewart, Jimmie
    Amin, Khalid
    LABORATORY INVESTIGATION, 2019, 99
  • [6] Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay
    Chauhan, Aastha
    Racila, Emilian
    Stewart, Jimmie
    Amin, Khalid
    MODERN PATHOLOGY, 2019, 32
  • [7] Gene and protein expression of MAGE, PD-L1, and associated immune landscape elements in non-small cell lung carcinoma (NSCLC), urothelial carcinoma (UC), squamous cell cancer of the head and neck (SCCHN), and cervical carcinoma (CC)
    Astrow, Stephanie H.
    Faiena, Izak
    Jain, Rajul
    Drakaki, Alexandra
    Chang, Wesley S.
    Fjeld, Clark C.
    Li, Jin
    Bot, Adrian
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [8] Determining PD-L1 expression in head and neck squamous cell carcinoma using immunohistochemistry
    Mishra, Prabha S.
    Sidhu, Avnit
    Dwivedi, Gunjan
    Mulajker, Deepak S.
    Awasthi, Shivali
    INDIAN JOURNAL OF CANCER, 2022, 59 (04) : 474 - 479
  • [9] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Delafoy, A.
    Uguen, A.
    Key, S.
    Lucia, F.
    Lemasson, G.
    Abgral, R.
    Dissaux, G.
    Pradier, O.
    Schick, U.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S627 - S628
  • [10] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Delafoy, Alice
    Uguen, Arnaud
    Lemasson, Gilles
    Conan-Charlet, Virginie
    Pradier, Olivier
    Lucia, Francois
    Schick, Ulrike
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (01) : 343 - 351
12345